key: cord-0807334-tbomvjqt
authors: Vogt, F.; Kurup, K.; Mussleman, P.; Habrun, C.; Crowe, M.; Woodward, A.; Jaramillo-Gutierrez, G.; Kaldor, J.; Vong, S.; Del Rio Vilas, V.
title: Contact tracing indicators for COVID-19: rapid scoping review and conceptual framework
date: 2021-05-19
journal: nan
DOI: 10.1101/2021.05.13.21257067
sha: 0ee2be7233fb9d81434978c91ef8e76414f007ce
doc_id: 807334
cord_uid: tbomvjqt

Background: Contact tracing is one of the key interventions in response to the COVID-19 pandemic but its implementation varies widely across countries. There is little guidance on how to monitor contact tracing performance, and no systematic overview of indicators to assess contact tracing systems or conceptual framework for such indicators exists to date. Methods: We conducted a rapid scoping review using a systematic literature search strategy in the peer-reviewed and grey literature as well as open source online documents. We developed a conceptual framework to map indicators by type (input, process, output, outcome, impact) and thematic area (human resources, financial resources, case investigation, contact identification, contact testing, contact follow up, case isolation, contact quarantine, transmission chain interruption, incidence reduction). Results: We identified a total of 153 contact tracing indicators from 1,555 peer-reviewed studies, 894 studies from grey literature sources, and 15 sources from internet searches. Two-thirds of indicators were process indicators (102; 67%), while 48 (31%) indicators were output indicators. Only three (2%) indicators were input indicators. Indicators covered seven out of ten conceptualized thematic areas, with more than half being related to either case investigation (37; 24%) or contact identification (44; 29%). There were no indicators for the input area 'financial resources', the outcome area 'transmission chain interruption', and the impact area 'incidence reduction'. Conclusions: Almost all identified indicators were either process or output indicators focusing on case investigation, contact identification, case isolation or contact quarantine. We identified important gaps in input, outcome and impact indicators, which constrains evidence-based assessment of contact tracing systems. A universally agreed set of indicators is needed to allow for cross-system comparisons and to improve the performance of contact tracing systems.

peer-reviewed and grey literature as well as open source online documents. We developed a 23 conceptual framework to map indicators by type (input, process, output, outcome, impact) and 24 thematic area (human resources, financial resources, case investigation, contact identification, 25 contact testing, contact follow up, case isolation, contact quarantine, transmission chain 26 interruption, incidence reduction). 27

Results: We identified a total of 153 contact tracing indicators from 1,555 peer-reviewed studies, 894 28 studies from grey literature sources, and 15 sources from internet searches. Two-thirds of indicators 29 were process indicators (102; 67%), while 48 (31%) indicators were output indicators. Only three 30 (2%) indicators were input indicators. Indicators covered seven out of ten conceptualized thematic 31 areas, with more than half being related to either case investigation (37; 24%) or contact 32 identification (44; 29%). There were no indicators for the input area "financial resources", the 33 outcome area "transmission chain interruption", and the impact area "incidence reduction". 34

Conclusions: Almost all identified indicators were either process or output indicators focusing on 35 case investigation, contact identification, case isolation or contact quarantine. We identified 36 important gaps in input, outcome and impact indicators, which constrains evidence-based 37 assessment of contact tracing systems. A universally agreed set of indicators is needed to allow for 38 cross-system comparisons and to improve the performance of contact tracing systems. 39 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 19, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 3 Background 40

Contact tracing has become one of the key interventions in response to the coronavirus disease 2019 41 pandemic in many countries, and is considered an indispensable outbreak response 42 activity to reduce new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections (1, 43 2). Contact tracing systems for SARS-CoV-2 aim to interrupt transmission chains by investigating 44 people who had contact with a probable or confirmed case, and quarantining or isolating infected 45 and exposed individuals in a timely manner, thereby reducing the occurrence of future transmission 46 events (3). While identifying and notifying contacts is a core part of contact tracing, other closely 47 related activities like case investigation, testing of contacts, and case isolation and quarantining of 48 contacts, are commonly understood to be part of contact tracing (4). 49

The World Health Organization (WHO) currently recommends contact tracing for persons with 50 exposure to a probable or confirmed case during the infectious period, defined as face to face 51 contact within one meter for 15 minutes or more, or direct physical contact regardless of duration. 52

The infectious period is defined as two days before until ten days after symptom onset for 53 symptomatic cases, and two days before until ten days after a positive test for asymptomatic cases 54

(3). The implementation of contact tracing and related activities varies widely across countries 55 depending on local public health guidance and resources. For example, prioritization of high-risk 56 contacts according to risk classification is often done in high burden settings and/or low-resource 57 contexts, e.g. by focusing on household members or other close contacts, contacts exposed during 58 crowded or closed settings, or contacts exposed to cases at the peak of their infectiousness (3). 59

Similarly, local guidance varies on whether or not all contacts should be tested or whether only 60 selective testing of close contacts should be done, and whether or not quarantine is recommended 61 or compulsory, and whether it is organized at designated facilities or at the contacts' home (2, 5). 62

Despite contact tracing having a pivotal role in the COVID-19 response, there is little guidance on 63 how to monitor and assess performance of contact tracing systems, a gap that was identified early in 64 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 19, 2021. ; https://doi.org/10.1101/2021.05.13.21257067 doi: medRxiv preprint global or regional level to assess and monitor the performance and quality of contact tracing systems 66 for COVID-19 (5), which makes it impossible to assess performance over time and to identify 67 benchmarks across similar settings (8). While several contact tracing indicators have recently been 68

proposed both in the peer-reviewed literature as well as in non-peer reviewed documents online, 69 this often occurs without any conceptual framing or systematic development and selection of 70

No systematic overview of indicators proposed for the assessment of contact tracing systems during 72 the COVID-19 pandemic and no conceptual framework to map and identify gaps in the proposed 73 indicators exist to date (3). This gap, identified already during the WHO consultation workshop in 74

June 2020 (7), hinders the development of a more comprehensive monitoring and evaluation 75 framework, thus ultimately impeding the improvement of contact tracing for We aimed to close this gap by undertaking a systematic scoping review. Our objective was to 77 systematically scope the peer-reviewed and grey literature as well as other online resources for 78 indicators that can be used to assess the performance of COVID-19 contact tracing systems, and to 79 propose a conceptual framework for contact tracing indicators during the COVID-19 pandemic. 80

Understanding the current landscape of proposed contact tracing indicators and to establish a 81 conceptual framework for these indicators is a prerequisite towards the development of an 82 evaluation tool built on a core set of indicators for the systematic reporting of COVID-19 contact 83 tracing activities across countries. 84

We conducted a rapid scoping review using a systematic literature search strategy with the aim to 86 understand the landscape of contact tracing indicators for COVID-19. The design, conduct, and 87 reporting of this study was guided by the WHO guidance on rapid reviews (9) and the PRISMA 88 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 19, 2021. ; https://doi.org/10.1101/2021.05.13.21257067 doi: medRxiv preprint Extension for Scoping Reviews (10). The study protocol was registered in the international 89 prospective register PROSPERO prior to starting data collection (ref no CRD42020218057). 90

While the search process included locating literature in the three core health sciences databases 91

PubMed, Embase, and Cochrane Library, our search also relied heavily on grey literature sources. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 19, 2021. ; https://doi.org/10.1101/2021.05.13.21257067 doi: medRxiv preprint 6 journal/publishing site, the digital object identification number or uniform resource locator, 114 geographical scope, and article/document type were extracted. 115

We developed a conceptual framework to map the extracted contact tracing indicators, with 116 indicators being categorized by indicator type and grouped by thematic area. Indicators were also 117 classified by type of measurement. Exact duplications were removed but otherwise indicators and 118 benchmarks, where proposed, were mapped in the framework as presented in the source 119 documents. 120

We screened 1,555 peer-reviewed studies and 894 studies from grey literature sources. After 122 screening and merging of results, we retained 9 peer-reviewed studies and 1 non-peer reviewed 123 study. Additionally, 15 sources were retained from the internet searches (see flow diagram in Figure  124 1 and citation details in Supporting Information File 3) . 125

We identified a total of 153 contact tracing indicators from the included sources. Our conceptual 126 framework consisted of five types of indicators (input, process, output, outcome, and impact) with 127 ten thematic areas (human resources, financial resources, case investigation, contact identification, 128 contact testing, contact follow up, case isolation, contact quarantine, transmission chain 129 interruption, incidence reduction). All identified indicators were mapped into this conceptual 130 framework (see Supporting Information File 4 and Table 1 ): Two-thirds of indicators were classified 131 as process indicators (102; 67%), while 48 (31%) of indicators were classified as output indicators. 132

Only three (2%) indicators were input indicators. The identified indicators covered seven of the ten 133 conceptualized thematic areas, with more than half of the indicators being related either to case 134 investigation (37; 24%) or contact identification (44; 29%). There were no indicators for the input 135 area "financial resources", the outcome area "transmission chain interruption", and the impact area 136 "incidence reduction". 137 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 19, 2021. ; https://doi.org/10.1101/2021.05.13.21257067 doi: medRxiv preprint 7 The majority of indicators (89, 58%) had a percentage, proportion or ratio (e.g. proportion of 138 identified contacts contacted) as type of measurement. Absolute numbers (e.g. number of contacts 139 tested) and time duration (e.g. time from exposure of a contact with a case to notification) were the 140 type of measurement in 41 (27%) and 35 (23%) indicators, respectively. Thirty-eight (24.8%) 141

indicators included a proposed target benchmark to measure success (e.g. proportion of contacts of 142 COVID-19 positive contacts who become COVID-19 positive: target: <1%). 143

Indicators are means to measure achievements and can be used to assess and monitor the 145 performance of systems as part of a logical framework (13). In the evaluation of public health 146 systems, indicators are often classified as input, process, output, outcome and impact indicators (14). 147

While input indicators are about what is needed to run a system, and process indicators are about 148 the activities undertaken by the system, output, outcome, and impact indicators are three different 149 ways to measure the external effects of a system ranging from immediate effects (output) to higher-150 level goals (impact) (15, 16). 151

We systematically collated all indicators that have been proposed in the peer-reviewed, grey and 152 online literature to assess the performance of contact tracing systems, and we developed a 153 conceptual framework to assess the coverage of core thematic areas by the identified indicators. We 154 found the 153 identified indicators to focus heavily on the process performance of case investigation, 155 contact identification, and testing of contacts; and on the output performance of case isolation and 156 contact quarantine. We only identified a very small number of input indicators and no outcome or 157 impact indicators (see Supporting Information File 4 and Table 1 ). 158

The vast majority of our identified indicators were either process or output indicators. This focus on 159 the mid-level indicator types is not uncommon in health systems assessments (17). For process 160 indicators it is often the availability of data that explains their frequent use, and for output indicators 161 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 19, 2021. ; https://doi.org/10.1101/2021.05.13.21257067 doi: medRxiv preprint 8 this is largely due to the immediacy of the measured effects (16, 18). Outcome and impact indicators, 162 on the other hand, measure more distal long-term effects, and are harder to measure and to 163 attribute to a specific system, hence their absence in our study was hardly surprising given that 164 COVID-19 contact tracing systems were built or adapted under immense time pressure in the midst 165 of a global pandemic. 166

Building on the understanding of COVID-19 contact tracing activities as established by WHO, we 167 conceptualized ten core thematic areas which a comprehensive evaluation approach should cover 168 across the different indicator types (see Supporting Information File 4 and Table 1) indicators on human and financial resources were clearly underrepresented, which can hardly be 180 explained by lack of data availability for these indicators. Instead, this gap could indicate that 181 efficiency is not a priority. It is likely that program managers were generally more concerned about 182 the middle and proximal front end of the system, i.e. process and output, instead of the back end 183 (input). This is somewhat expected although counterintuitive given the large amount of resources 184 that contact tracing consumes, especially in community transmission settings. Given that adequate 185 human resources and in particular training has been identified as a main factor of successful contact 186 tracing systems, this area requires better evaluation tools. WHO provides specific guidance for 187 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 19, 2021. ; https://doi.org/10.1101/2021.05.13.21257067 doi: medRxiv preprint member states to estimate workforce needs depending on the specific transmission scenario (19), 188 which could be used to develop additional indicators to address these gaps. 189

Overall, we noticed substantial duplications and strong similarities between indicators, in particular 190 in the thematic areas that were the most heavily covered (see Supporting Information File 4), which 191 can be explained in large parts by a lack of standardized terminology and use of epidemiological 192 concepts in the non-scientific literature. Most of the identified sources did not provide clear 193 definitions of the terms used. There is a need to harmonize the understanding and use of 194 terminology and concepts related to contact tracing. Also, the benchmarks that were proposed for 195 about a quarter of the identified indicators were often not contextualized, which made it difficult to 196 establish whether these were considered minimum standards or indicators of success, and to 197 determine the rationale behind the choice of certain thresholds. Furthermore, indicators using 198 measures of centrality were based either on averages (means) or medians, but none of the identified 199 indicators aimed to measure the dispersion of transmission risks between cases and contacts, which 200 is increasingly recognized as an important factor in the control of . 201

Our study was subject to several limitations. First, our search was restricted to English, thus 202 documents in any other language would have been missed. Second, we restricted our search to the 203 three known human coronaviruses with epidemic potential due to their similar epidemiological 204 profiles. Contact tracing indicators for other epidemic-prone infectious diseases were thus missed. 205

Third, we did not assess system-wide indicators, e.g. those relating to coordination across units 206 and/or levels, or governance. Fourth, we were not able to record the total number of websites 207 searched during our internet search, and could therefore only report the number of websites from 208 which indicators were included for this study (see Figure 1 ). Fifth, it is possible that there is 209 publication bias across indicator categories, with input indicators being underrepresented in 210 published or online documents compared to process and output indicators due to perceived lower 211 operational relevance by public health officials in charge of contact tracing systems. This might be 212 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 19, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 particularly the case for indicators that are more relevant at peripheral levels of health systems 213 compared to priorities at central levels. Sixth, though we applied a very systematic search strategy 214 for the peer-reviewed and grey literature, this was not a full systematic review and therefore did not 215 include or adhere to all items recommended for full systematic reviews (21). We did, however, follow 216 existing guidance for the rapid conduct of scoping reviews (9, 10) and report on all items of the 217 PRISMA-ScR Checklist (see Supporting Information File 5). 218

We provide the first comprehensive mapping of published indicators to assess the performance of 219 contact tracing systems during the COVID-19 pandemic. Our findings can assist countries to develop 220 new indicators for their own contact tracing systems or to complement existing lists of indicators. 221

Despite the recent development of several effective vaccines against SARS-CoV-2, contact tracing will 222 remain a cornerstone in the public health response worldwide until the very end of the pandemic (3). 223

The importance yet absence of comprehensive guidance on how to assess performance of contact 224 tracing systems across countries has been recognized (2, 5). The centerpiece of such global guidance 225 should be a set of core indicators that are widely accepted, operationally relevant, and easy to report 226 across contact tracing systems. This core set might even be useful in future epidemics with similar 227 epidemiological characteristics as SARS-CoV-2. The development of such a core set of indicators will 228 require a coordinated, methodologically robust ranking and consensus seeking undertaking, and our 229 study provides important insights to inform such initiatives. 230

Almost all identified indicators were either process or output indicators with a strong focus on case 232 investigation, contact identification, case isolation or contact quarantine. Important gaps in process, 233 outcome and impact indicators exist. Duplications, inconsistent use of terminology and unclear 234 choice for benchmarks were common. A universally agreed set of indicators is needed to allow for 235 comprehensive cross-system evaluations in order to improve the performance of COVID-19 contact 236 tracing systems. 237 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 19, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 Tables 238 CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 19, 2021. ; https://doi.org/10.1101/2021.05.13.21257067 doi: medRxiv preprint CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 19, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 

Multipronged Approach to Fight the COVID-19 Pandemic

Global strategies and effectiveness 256 for COVID-19 prevention through contact tracing, screening, quarantine, and isolation: a systematic 257 review

World Health Organization. Contact tracing in the context of COVID-19 -Interim guidance

Contact_Tracing-2021.1-eng.pdf?sequence=24&isAllowed=y. Last updated 1 February 2021; for Disease Control and Prevention

A comparative analysis of COVID-19 contact 266 tracing guidance across WHO member states and regions. COVID-19 Knowledge Hub

World Health Organization. COVID-19 Strategic Preparedness and Response -Monitoring 271 and evaluation framework, draft updated 5

Online global 275 consultation on contact tracing for COVID-19. Available from 276 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity

UK National Health System. The Good Indicators Guide: understanding how to use and 279 choose indicators

Rapid reviews to strengthen health policy and systems: a practical guide

World Health Organization. Rapid reviews to strengthen health policy and systems: a practical guide

PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and 290

Explanation

Sartorius RH. The Logical Framework Approach to Project Design and Management

Last updated

UK Department for International Development

Outcomes and Impacts in Security and Justice Programming

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)The copyright holder for this preprint this version posted May 19, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021